ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Medidata Patient Insights Leader Alicia Staley Honored by National Coalition for Cancer Survivorship

Stovall Award is Given Annually to Those Improving the Lives of Cancer Survivors and Their Families

  • Staley recognized for her exceptional patient advocacy work at the annual Ellen L. Stovall Award Reception in Washington, D.C.
  • Three-time cancer survivor and founder of the popular #BCSM (breast cancer social media) community
  • Founded Medidata’s Patient Insights Program and pioneered the company’s Patient Centricity by Design process

Medidata, a Dassault Systèmes company, announced that vice president for Patient Engagement and leader of its Patient Insights Board Alicia Staley has been honored with the Ellen L. Stovall Award for patient advocacy from the National Coalition for Cancer Survivorship (NCCS).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221122005590/en/

NCCS CEO Shelley Fuld Nasso (left), Medidata vice president for Patient Engagement Alicia Staley Photo: Leslie E. Kossoff/LK Photos

NCCS CEO Shelley Fuld Nasso (left), Medidata vice president for Patient Engagement Alicia Staley Photo: Leslie E. Kossoff/LK Photos

“Alicia’s influence as a leader reaches a national and, in fact, a global audience. Alicia is one of the most effective community builders, a collaborator, and a facilitator within groups of people seeking to improve care for cancer patients and their families,” said Anne Marie Mercurio, a patient advocate who sits on the Medidata Patient Insights Board. “Her first-hand knowledge of cancer care and delivery after three separate primary diagnoses spanning several decades has afforded her a unique perspective and a variety of experiences which she infuses into everything she does.”

Staley leads Medidata’s Patient Insights Board, and pioneered its proprietary Patient Centricity by Design process to guide the creation of protocols and patient-facing solutions to improve clinical trial experiences, expedite clinical trial delivery timelines, and bring therapies to market faster.

“Alicia is one of the most respected voices and creative influences in increasing patient engagement in clinical trials,” said Anthony Costello, Medidata Patient Cloud CEO. “She consistently brings the patient perspective to the development of new innovation across all of Medidata’s technologies.”

NCCS recognized Staley at the annual Ellen L. Stovall Award Reception in Washington, D.C.

“Alicia has dedicated her life to advocacy – helping other cancer survivors navigate their treatment and survivorship, connecting advocates with researchers, and making sure that people touched by cancer have a seat at the table when decisions are made,” said NCCS CEO Shelley Fuld Nasso. “As a co-founder of the breast cancer social media (#BCSM) community, she created a worldwide network of patients, advocates, caregivers, clinicians, and researchers, providing support and advocating for better cancer care.”

The NCCS mission is to advocate for quality cancer care for all people touched by cancer. Founded by and for cancer survivors, NCCS created the widely accepted definition of survivorship and defines someone as a cancer survivor from the time of diagnosis and for the balance of life.

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

About Medidata

Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, 2,000+ customers and partners access the world's most trusted platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: FR0014003TT8, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production to achieve a more sustainable world for patients, citizens, and consumers. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com

3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Systèmes, a French “société européenne” (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and/or other countries.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+0.00 (0.00%)
AAPL  270.37
+0.00 (0.00%)
AMD  256.12
+0.00 (0.00%)
BAC  53.45
+0.00 (0.00%)
GOOG  281.82
+0.00 (0.00%)
META  648.35
+0.00 (0.00%)
MSFT  517.81
+0.00 (0.00%)
NVDA  202.49
+0.00 (0.00%)
ORCL  262.61
+0.00 (0.00%)
TSLA  456.56
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.